[{"Assets_0_Q3_USD":245143000.0,"CommonStockDividendsPerShareDeclared_3_Q3_USD":0.45,"CommonStockDividendsPerShareDeclared_1_Q3_USD":0.125,"EarningsPerShareBasic_3_Q3_USD":0.38,"EarningsPerShareBasic_1_Q3_USD":0.01,"EarningsPerShareDiluted_1_Q3_USD":0.01,"EarningsPerShareDiluted_3_Q3_USD":0.37,"NetIncomeLoss_3_Q3_USD":15831000.0,"NetIncomeLoss_1_Q3_USD":240000.0,"StockholdersEquity_0_Q3_USD":167549000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":42593000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":42556000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":42203000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":42184000.0,"Ticker":"VIVO","CIK":"794172","name":"MERIDIAN BIOSCIENCE INC","OfficialName":"Meridian Bioscience Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1192599275.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20170809"}]